What is US Neurosurgical Holding Selling, General, & Admin. Expense?
Selling, general, & admin. expense (SGA) includes the direct and indirect costs and all general and administrative expenses of a company. US Neurosurgical Holding's selling, general, & admin. expense for the
three
months ended in Mar. 2024 was $0.48 Mil.
Its selling, general, & admin. expense for the trailing twelve months (TTM) ended in Mar. 2024 was $1.11 Mil.
US Neurosurgical Holding Selling, General, & Admin. Expense Historical Data
The historical data trend for US Neurosurgical Holding's Selling, General, & Admin. Expense can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
US Neurosurgical Holding Selling, General, & Admin. Expense Chart
Competitive Comparison of US Neurosurgical Holding's Selling, General, & Admin. Expense
For the Medical Care Facilities subindustry, US Neurosurgical Holding's Selling, General, & Admin. Expense, along with its competitors' market caps and Selling, General, & Admin. Expense data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
US Neurosurgical Holding's Selling, General, & Admin. Expense Distribution in the Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, US Neurosurgical Holding's Selling, General, & Admin. Expense distribution charts can be found below:
* The bar in red indicates where US Neurosurgical Holding's Selling, General, & Admin. Expense falls into.
US Neurosurgical Holding Selling, General, & Admin. Expense Calculation
Selling, General, & Admin. Expense (SGA) includes the direct and indirect costs and all general and administrative expenses of a company. For instance, personnel cost, advertising, rent, communication costs are all part of SGA.
Selling, General, & Admin. Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.11 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
US Neurosurgical Holding (OTCPK:USNU) Selling, General, & Admin. Expense Explanation
An efficient operation keeps SGA costs low and thus has higher profit margin. The percentage of SGA relative to total revenue is an indication of how efficiently the company operates. Compare this percentage among the companies in the same industry is a good way of finding more efficient operations. A comparison of the SGA cost relative to the revenue with the historical value can also be an indication of how efficient the company has become.
Warren Buffett likes companies with consistent SGA as the percentage of gross profit.
Companies with no durable competitive advantage show wild variation in SG&A as % of Gross Profit.
If SGA is less than 30% of Gross Profit, it is fantastic. If SGA is nearing 100%, it is is in highly competitive industry.
US Neurosurgical Holding Selling, General, & Admin. Expense Related Terms
Thank you for viewing the detailed overview of US Neurosurgical Holding's Selling, General, & Admin. Expense provided by GuruFocus.com. Please click on the following links to see related term pages.
US Neurosurgical Holding (US Neurosurgical Holding) Business Description
US Neurosurgical Holding Inc operates as a holding company in United State. It is a medical services company that partners with hospitals and physicians to operate facilities utilizing artistic and inventive technologies in medical treatment and diagnosis. It is engaged in providing medical treatment and diagnosis services that include stereotactic radiosurgery centers, utilizing gamma knife technology, and holds interests in radiological treatment facilities. The company is focusing on establishing cancer centers using intensity-modulated radiation therapy. Its gamma knife is a stereotactic radiosurgical device used to treat brain tumors and other malformations of the brain without invasive surgery.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
USNU has been successfully added to your 